Skip to main content
Erschienen in: International Journal of Mental Health and Addiction 5/2021

23.04.2020 | Original Article

Psychology Student Attitudes and Beliefs Toward Cannabis for Mental Health Purposes: a Cross National Comparison

verfasst von: Marilyn Clark, Valentina Gritsenko, Jamie S. Bonnici, Tatyana Marinova, Alexander Reznik, Richard Isralowitz

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Medical and allied health sciences professionals are increasingly dealing with clients who use cannabis for medical and recreational purposes. Yet, university curricula in many countries do not provide education for students and professionals in medicine and allied health fields including psychology about medical cannabis (MC) use. This study compares the attitudes and beliefs toward medical cannabis among psychology students at universities in Malta and Russia. Data were collected through an online survey for Maltese students and a pen-and-paper survey for Russian students. The present study did not evidence any difference based on gender. However, students who reported personal cannabis use, regardless of country status, were more likely to recommend MC for patient treatment and believe cannabis use does not pose serious physical or mental health risks. Significant differences among the students from Malta and Russia may be attributed to the legal standing of MC in the countries involved. However, a key finding from all students is the dearth of education about cannabis for health-related conditions and the need for curricula based on evidence-based research for informed decision-making.
Literatur
Zurück zum Zitat Ananth, P., Reed-Weston, A., & Wolfe, J. (2018). Medical marijuana in pediatric oncology: A review of the evidence and implications for practice. Pediatric Blood & Cancer, 65(2), e26826.CrossRef Ananth, P., Reed-Weston, A., & Wolfe, J. (2018). Medical marijuana in pediatric oncology: A review of the evidence and implications for practice. Pediatric Blood & Cancer, 65(2), e26826.CrossRef
Zurück zum Zitat Ayu, A. P., De Jong, C. A., Pinxten, W. J. L., & Schellekens, A. F. (2016). Illness perceptions of addiction and substance use patterns among psychology students. Journal of Child and Adolescent Behavior, 4(1), 1000279. Ayu, A. P., De Jong, C. A., Pinxten, W. J. L., & Schellekens, A. F. (2016). Illness perceptions of addiction and substance use patterns among psychology students. Journal of Child and Adolescent Behavior, 4(1), 1000279.
Zurück zum Zitat Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., De Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., et al. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology, 36(6), 1219–1226.CrossRef Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., De Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., et al. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology, 36(6), 1219–1226.CrossRef
Zurück zum Zitat Bostwick, J. M. (2012). Blurred boundaries: The therapeutics and politics of medical marijuana. Mayo Clinic Proceedings, 87(2), 172–186.CrossRef Bostwick, J. M. (2012). Blurred boundaries: The therapeutics and politics of medical marijuana. Mayo Clinic Proceedings, 87(2), 172–186.CrossRef
Zurück zum Zitat Breault, J. L. (2006). Protecting human research subjects: The past defines the future. The Ochsner Journal, 6(1), 15–20.PubMedPubMedCentral Breault, J. L. (2006). Protecting human research subjects: The past defines the future. The Ochsner Journal, 6(1), 15–20.PubMedPubMedCentral
Zurück zum Zitat Caligiuri, F. J., Ulrich, E. E., & Welter, K. J. (2018). Pharmacy student knowledge, confidence and attitudes toward medical cannabis and curricular coverage. American Journal of Pharmaceutical Education, 82(5), 424–432.CrossRef Caligiuri, F. J., Ulrich, E. E., & Welter, K. J. (2018). Pharmacy student knowledge, confidence and attitudes toward medical cannabis and curricular coverage. American Journal of Pharmaceutical Education, 82(5), 424–432.CrossRef
Zurück zum Zitat Chan, M. H., Knoepke, C. E., Cole, M. L., McKinnon, J., & Matlock, D. D. (2017). Colorado medical students’ attitudes and beliefs about marijuana. Journal of General Internal Medicine, 32(4), 458–463.CrossRef Chan, M. H., Knoepke, C. E., Cole, M. L., McKinnon, J., & Matlock, D. D. (2017). Colorado medical students’ attitudes and beliefs about marijuana. Journal of General Internal Medicine, 32(4), 458–463.CrossRef
Zurück zum Zitat Cooper, R. E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J., & Asherson, P. (2017). Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. European Neuropsychopharmacology, 27(8), 795–808.CrossRef Cooper, R. E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J., & Asherson, P. (2017). Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. European Neuropsychopharmacology, 27(8), 795–808.CrossRef
Zurück zum Zitat Evanoff, A. B., Quan, T., Dufault, C., Awad, M., & Bierut, L. J. (2017). Physicians-in-training are not prepared to prescribe medical marijuana. Drug and Alcohol Dependence, 180, 151–155.CrossRef Evanoff, A. B., Quan, T., Dufault, C., Awad, M., & Bierut, L. J. (2017). Physicians-in-training are not prepared to prescribe medical marijuana. Drug and Alcohol Dependence, 180, 151–155.CrossRef
Zurück zum Zitat Grinspoon, L., & Bakalar, J. (1993). Marijuana: The forbidden medicine. New Haven: Yale University Press. Grinspoon, L., & Bakalar, J. (1993). Marijuana: The forbidden medicine. New Haven: Yale University Press.
Zurück zum Zitat Gritsenko, V., Konstantinov, V., Reznik, A., & Isralowitz, R. (2020). Russian Federation medical student knowledge, attitudes and beliefs toward medical cannabis. Complementary Therapies in Medicine, 48, 102274.CrossRef Gritsenko, V., Konstantinov, V., Reznik, A., & Isralowitz, R. (2020). Russian Federation medical student knowledge, attitudes and beliefs toward medical cannabis. Complementary Therapies in Medicine, 48, 102274.CrossRef
Zurück zum Zitat Hart, C., Ksir, C., & Ray, O. (2013). Drugs, society & human behavior (p. 496). New York: McGraw-Hill. Hart, C., Ksir, C., & Ray, O. (2013). Drugs, society & human behavior (p. 496). New York: McGraw-Hill.
Zurück zum Zitat Ishida, J. H., Zhang, A. J., Steigerwald, S., Cohen, B. E., Vali, M., & Keyhani, S. (2020). Sources of information and beliefs about the health effects of marijuana. Journal of General Internal Medicine, 35(1), 153–159.CrossRef Ishida, J. H., Zhang, A. J., Steigerwald, S., Cohen, B. E., Vali, M., & Keyhani, S. (2020). Sources of information and beliefs about the health effects of marijuana. Journal of General Internal Medicine, 35(1), 153–159.CrossRef
Zurück zum Zitat Kosiba, J. D., Maisto, S. A., & Joseph, W. (2019). Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine, 233, 181–192.CrossRef Kosiba, J. D., Maisto, S. A., & Joseph, W. (2019). Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine, 233, 181–192.CrossRef
Zurück zum Zitat Moeller, K. E., & Woods, B. (2015). Pharmacy students’ knowledge and attitudes regarding medical marijuana. American Journal of Pharmaceutical Education, 79(6), 1–8.CrossRef Moeller, K. E., & Woods, B. (2015). Pharmacy students’ knowledge and attitudes regarding medical marijuana. American Journal of Pharmaceutical Education, 79(6), 1–8.CrossRef
Zurück zum Zitat Moeller, K. E., McGuire, J. M., & Melton, B. L. (2020). A nationwide survey of pharmacy students’ knowledge and perceptions regarding medical cannabis. Journal of the American Pharmacists Association, 60(1), 218–224.CrossRef Moeller, K. E., McGuire, J. M., & Melton, B. L. (2020). A nationwide survey of pharmacy students’ knowledge and perceptions regarding medical cannabis. Journal of the American Pharmacists Association, 60(1), 218–224.CrossRef
Zurück zum Zitat National Academies of Sciences, Engineering, and Medicine (NASEM). (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, D.C.: National Academies Press. National Academies of Sciences, Engineering, and Medicine (NASEM). (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, D.C.: National Academies Press.
Zurück zum Zitat Orsolini, L., Chiappini, S., Volpe, U., De Berardis, D., Latini, R., Papanti, G. D., & Corkery, J. M. (2019). Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): A systematic review. Medicina, 55(9), 525.CrossRef Orsolini, L., Chiappini, S., Volpe, U., De Berardis, D., Latini, R., Papanti, G. D., & Corkery, J. M. (2019). Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): A systematic review. Medicina, 55(9), 525.CrossRef
Zurück zum Zitat Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020). Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry, 20(1), 24.CrossRef Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020). Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry, 20(1), 24.CrossRef
Zurück zum Zitat Stuart-Maver, S. L. (2020). Working with clients who self-medicate using cannabis: Ethical and clinical considerations for psychologists. Professional Psychology: Research and Practice, 51(1), 77–84.CrossRef Stuart-Maver, S. L. (2020). Working with clients who self-medicate using cannabis: Ethical and clinical considerations for psychologists. Professional Psychology: Research and Practice, 51(1), 77–84.CrossRef
Zurück zum Zitat Walsh, Z., Gonzalez, R., Crosby, K., Thiessen, M. S., Carroll, C., & Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15–29.CrossRef Walsh, Z., Gonzalez, R., Crosby, K., Thiessen, M. S., Carroll, C., & Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15–29.CrossRef
Zurück zum Zitat Zolotov, Y., Vulfsons, S., Zarhin, D., & Sznitman, S. (2018). Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis. International Journal of Drug Policy, 57, 4–10.CrossRef Zolotov, Y., Vulfsons, S., Zarhin, D., & Sznitman, S. (2018). Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis. International Journal of Drug Policy, 57, 4–10.CrossRef
Zurück zum Zitat Zolotov, Y., Vulfsons, S., & Sznitman, S. (2019). Predicting Physicians' intentions to recommend medical Cannabis. Journal of Pain and Symptom Management, 58(3), 400–407.CrossRef Zolotov, Y., Vulfsons, S., & Sznitman, S. (2019). Predicting Physicians' intentions to recommend medical Cannabis. Journal of Pain and Symptom Management, 58(3), 400–407.CrossRef
Metadaten
Titel
Psychology Student Attitudes and Beliefs Toward Cannabis for Mental Health Purposes: a Cross National Comparison
verfasst von
Marilyn Clark
Valentina Gritsenko
Jamie S. Bonnici
Tatyana Marinova
Alexander Reznik
Richard Isralowitz
Publikationsdatum
23.04.2020
Verlag
Springer US
Erschienen in
International Journal of Mental Health and Addiction / Ausgabe 5/2021
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI
https://doi.org/10.1007/s11469-020-00280-6

Weitere Artikel der Ausgabe 5/2021

International Journal of Mental Health and Addiction 5/2021 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.